Announce Date | 03/11/2025 |
EPS Normalized Actual | $1.19 (Beat by $0.06) |
EPS GAAP Actual | $1.19 (Beat by $0.06) |
Revenue Actual | $0.676538B |
Revenue Surprise | Beat by $676.538M |
Announce Date | 05/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.26584 |
EPS GAAP Estimate | $1.26584 |
Revenue Estimate | $0.704461198B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Apr 2027 | 4.51616 | 14.63 | 4.34064 | 4.72164 | -1 |
Apr 2026 | 4.51616 | 14.63 | 4.51616 | 4.51616 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Jan 2025) | 1.13 | -0.03681 | 0.676538B | -0.05% | -8.82M |
FQ4 2024 (Oct 2024) | -1.19 | -1.19 | 0.68196B | -4.47% | 681.96M |
FQ3 2024 (Jul 2024) | 1.21 | 1.21 | 0.682761B | 100% | 682.76M |
FQ2 2024 (Apr 2024) | 1.28 | 1.28 | 0.699923B | -5.46% | 699.92M |
FQ1 2024 (Jan 2024) | 1.14 | 1.14 | 0.676873B | -1.47% | 676.87M |
FQ4 2023 (Oct 2023) | -0.0333 | -0.0333 | 0.712447B | -3.27% | 712.45M |
FQ3 2023 (Jul 2023) | 0 | 0 | 0B | -INF% | 0M |
FQ2 2023 (Apr 2023) | 0.91 | 0.91 | 0.738124B | -69.1% | 738.12M |
FQ4 Announce Date
05/01/2025 (Pre-Market)
Consensus EPS Estimates
1.26584
Consensus Revenue Estimates
0.704461198B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (May 2027) | 1.49831 | -- | 1.48158 | 1.51478 | 0 |
FQ1 2027 (Jan 2027) | 1.32544 | -- | 1.305 | 1.35561 | 1 |
FQ4 2026 (Oct 2026) | 1.43091 | -- | 1.40885 | 1.46348 | 0 |
FQ3 2026 (Jul 2026) | 1.37609 | -- | 1.35487 | 1.40741 | 0 |
FQ2 2026 (May 2026) | 1.43473 | -- | 1.41871 | 1.45051 | 1 |
FQ1 2026 (Jan 2026) | 1.28863 | 12.31 | 1.28863 | 1.28863 | 0 |
FQ4 2025 (Oct 2025) | 1.3556 | 187.78 | 1.33832 | 1.37492 | 1 |
FQ3 2025 (Jul 2025) | 1.20872 | -0.11 | 1.19332 | 1.22594 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (May 2027) | 0.76B | -- | 0.75B | 0.76B | 1 |
FQ1 2027 (Jan 2027) | 0.72B | -- | 0.71B | 0.73B | 2 |
FQ4 2026 (Oct 2026) | 0.75B | -- | 0.74B | 0.76B | 1 |
FQ3 2026 (Jul 2026) | 0.72B | -- | 0.71B | 0.73B | 1 |
FQ2 2026 (May 2026) | 0.74B | -- | 0.74B | 0.75B | 2 |
FQ1 2026 (Jan 2026) | 0.73B | 6.82 | 0.73B | 0.73B | 1 |
FQ4 2025 (Oct 2025) | 0.76B | 10.46 | 0.75B | 0.77B | 0 |
FQ3 2025 (Jul 2025) | 0.72B | 5.77 | 0.72B | 0.73B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
6
Revenue # of Misses
1
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | 1.16681 | 1.13 | -0.03681 | -3.26% |
FQ4 2024 (Oct 2024) | -1.19 | -1.19 | 100% | |
FQ3 2024 (Jul 2024) | 1.21 | 1.21 | 100% | |
FQ2 2024 (Apr 2024) | 1.28 | 1.28 | 100% | |
FQ1 2024 (Jan 2024) | 1.14 | 1.14 | 100% | |
FQ4 2023 (Oct 2023) | -0.0333 | -0.0333 | 100% | |
FQ3 2023 (Jul 2023) | 0 | 0 | NAN% | |
FQ2 2023 (Apr 2023) | 0.91 | 0.91 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | $0.69B | $0.68B | $-8.82M | -1.3% |
FQ4 2024 (Oct 2024) | $0B | $0.68B | $681.96M | 100% |
FQ3 2024 (Jul 2024) | $0B | $0.68B | $682.76M | 100% |
FQ2 2024 (Apr 2024) | $0B | $0.7B | $699.92M | 100% |
FQ1 2024 (Jan 2024) | $0B | $0.68B | $676.87M | 100% |
FQ4 2023 (Oct 2023) | $0B | $0.71B | $712.45M | 100% |
FQ3 2023 (Jul 2023) | $0B | $0B | $0M | NAN% |
FQ2 2023 (Apr 2023) | $0B | $0.74B | $738.12M | 100% |